October 1, 2005; 18 years ago (2005-10-01) (merger of Dainippon Pharmaceutical & Sumitomo Pharmaceuticals)
Headquarters
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Osaka 541-0045, Japan
Key people
Masayo Tada, (president and CEO)
Products
Diagnostics
Food additives
Food ingredients
Pharmaceuticals
Veterinary medicines
Revenue
US$3.76 billion (¥387.69 billion) (FY 2013)
Net income
US$194.94 million (¥20.06 billion) (FY 2013)
Number of employees
7,009 (consolidated) 4,291 (non-consolidated) (as of June 30, 2014)
Website
Official website
Footnotes / references [1][2][3][4]
Sumitomo Pharma Co., Ltd. (住友ファーマ株式会社, Sumitomo Fāma Kabushiki-Gaisha) is a pharmaceutical company based in Japan. Its headquarters are in Chuo-ku, Osaka.[5]
The original Dainippon Pharmaceuticals (Dainippon Seiyaku) was established in 1885 by Nagayo Sensai, a graduate of Tekijuku – the first private medical school in Japan established by Ogata Kōan. It was set up as a wholly privately owned company funded by individuals from Tokyo and Osaka, with the land and buildings lent by the government. Technical expertise for the enterprise was provided by Shibata Shokei and Nagai Nagayoshi.
The company started its operation in 1885 with equipment imported from Germany. The main products were tincture and other similar drugs listed in the Japanese Pharmacopoeia. Among them was ephedrine, an anti-asthma drug invented by Nagai. In 1893, however, Nagai left the company and the business started to post operating losses. In 1898 it was acquired by Osaka Seiyaku.
The company is most well known for producing Philopon during WWII for the Imperial Japanese military.
(Osaka Pharmaceutical).[6]
Another origin of the company began as Sumitomo Pharmaceuticals, incorporated in 1984 as a subsidiary of Sumitomo Chemical (holding 77.8% of the share as of 2006).[7] Dainippon and Sumitomo merged on October 1, 2005, to create Dainippon Sumitomo Pharma.[8] As a result, Sumitomo Chemical has 50.2% ownership in Dainippon Sumitomo Pharma as of March 31, 2014.[2]
On April 1, 2022, the company was renamed from Sumitomo Dainippon Pharma to Sumitomo Pharma.
^"Corporate Profile". Dainippon Sumitomo Pharma. Retrieved September 13, 2014.
^ ab"Fact Book 2014" (PDF). Dainippon Sumitomo Pharma. Retrieved November 3, 2011.
^"Company Snapshot". Bloomberg Businessweek. Archived from the original on September 13, 2014. Retrieved September 13, 2014.
^"Company Profile". Bloomberg L.P. Retrieved September 13, 2014.
^"Company Summary". Google Finance. Retrieved September 13, 2014.
^Odagiri, Hiroyuki (1996). Technology and Industrial Development in Japan. Clarendon Press, Oxford. p. 239. ISBN 0-19-828802-6.
^連結子会社の合併に関するお知らせ (PDF) (in Japanese). Sumitomo Chemical. November 25, 2004. Retrieved November 3, 2011.
^"Corporate History". Dainippon Sumitomo Pharma. Retrieved November 3, 2011.
SumitomoPharma Co., Ltd. (住友ファーマ株式会社, Sumitomo Fāma Kabushiki-Gaisha) is a pharmaceutical company based in Japan. Its headquarters are in Chuo-ku, Osaka...
On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of SumitomoPharma America, Inc., a science-based, technology-driven biopharmaceutical company...
The Sumitomo Group (Japanese: 住友グループ, Hepburn: Sumitomo Gurūpu) is a Japanese corporate group and keiretsu that traces its roots to the zaibatsu groups...
with Saudi Aramco. Sumitomo Pharmaceuticals and Dainippon Pharmaceuticals merged to form Dainippon SumitomoPharma. 2007: Sumitomo Chemical acquired the...
Sumitomo Corporation (Japanese: 住友商事株式会社, Hepburn: Sumitomo Shōji kabushiki gaisha) is one of the largest worldwide sōgō shōsha general trading companies...
Sumitomo Rubber Industries, Ltd. (住友ゴム工業株式会社, Sumitomo Gomu Kōgyo Kabushiki-gaisha) is a global tire and rubber company based in Japan. It is part of the...
announced plans to merge with Sumitomo Metal Industries. With Nippon Steel producing ~26.5 million tonnes of steel per year and Sumitomo making ~11 million tonnes...
Multilab for R$540 million. In June, Takeda announced it would acquire URL Pharma, then run by the founder's son Richard Roberts, for US$800 million. In September...
discovered by Uno and colleagues in 1972 and launched by Dainippon SumitomoPharma (formerly Dainippon Pharmaceutical) in 1989 as Excegran in Japan. It...
Sumitomo Heavy Industries, Ltd. (住友重機械工業株式会社, Sumitomo Jūkikai Kōgyō Kabushiki-gaisha) (SHI) is an integrated manufacturer of industrial machinery, automatic...
Sumitomo Life Insurance Company (住友生命保険相互会社, Sumitomo Seimei Hoken Sōgo-gaisha, Sumisei) is a mutual life insurance company in Japan, founded in 1907...
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from...
battle each other head-to-head with lethal antlers. Founded in 1947 as Sumitomo Metal Industries Factory Football Club in Osaka and moved to Kashima, Ibaraki...
and Sunovion Pharmaceuticals (which was subsequently merged into SumitomoPharma) using PsychoGenics' behavior and AI-based phenotypic drug discovery...
antipsychotic of the azapirone family. It was introduced in Japan by Dainippon SumitomoPharma in 2001 for the treatment of schizophrenia and acute cases of bipolar...
Sumitomo Electric Industries, Ltd. (住友電気工業株式会社, Sumitomo Denki Kōgyō) is a manufacturer of electric wire and optical fiber cables. Its headquarters are...
Market on June 11". PHARMA JAPAN. Archived from the original on 10 October 2022. Retrieved 10 October 2022. "Sumitomo Dainippon Pharma Announces Approval...
bankruptcy and was only saved through the intervention of Sumitomo keiretsu group, namely Sumitomo Bank, and the company's subcontractors and distributors...
Sumitomo Metal Industries, Ltd. (住友金属工業株式会社, Sumitomo Kinzoku Kōgyō Kabushiki-gaisha) was a steel manufacturer based in Osaka, Japan until it merged with...
was the origin in the shipbuilding of Sumitomo Heavy Industries. It was made by Enomoto Takeaki. However, Sumitomo Heavy Industries moved Uraga Dock to...
photofinishing and graphic arts equipment and materials. Fujifilm is part of the Sumitomo Mitsui Financial Group financial conglomerate (keiretsu). Fuji Photo Film...
Global Information
US$3.76 billion (¥387.69 billion) (FY 2013)